Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 291.00
Change Today +17.00 / 6.20%
Volume 8.9M
INAF On Other Exchanges
Symbol
Exchange
Indonesia
As of 5:10 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

indofarma tbk pt (INAF) Snapshot

Open
$275.00
Previous Close
$274.00
Day High
$292.00
Day Low
$272.00
52 Week High
12/10/14 - $410.00
52 Week Low
10/6/14 - $153.00
Market Cap
901.9B
Average Volume 10 Days
2.5M
EPS TTM
$0.37
Shares Outstanding
3.1B
EX-Date
05/3/13
P/E TM
783.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for INDOFARMA TBK PT (INAF)

Related News

No related news articles were found.

indofarma tbk pt (INAF) Related Businessweek News

No Related Businessweek News Found

indofarma tbk pt (INAF) Details

PT Indofarma (Persero), Tbk develops, manufactures, and sells generic drugs, over the counter, and branded generic drugs primarily in Indonesia. It also trades in and distributes drugs, medical devices, diagnostic products, and hospital furniture. The company was formerly known as Pharmaceutical Production Center and changed its name to PT Indofarma (Persero), Tbk in January 1996. The company was founded in 1918 and is based in Bekasi, Indonesia. It has an additional office in Jakarta, Indonesia.

1,804 Employees
Last Reported Date: 03/10/15
Founded in 1918

indofarma tbk pt (INAF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

indofarma tbk pt (INAF) Key Developments

Indofarma and Kimia Farma To Merge

The Indonesian government will decide on a planned merger between PT Kimia Farma (Persero) Tbk (JKSE:KAEF) and Pt Indofarma Persero Tbk (JKSE:INAF) in the week ending December 12, 2014. Indonesian state enterprises minister Rini Soemarno said the planned merger between Indofarma and Kimia Farma into a holding company will be a government priority, Bisnis Indonesia quoted her as saying.

Indofarma To Sell 20% Stake In Unit Via Private Placement

Pt Indofarma Persero Tbk (JKSE:INAF) plans to raise $20 million by selling 20% stake in PT Indofarma Global Medica via a private placement, said Corporate Secretary Yasser Arafat. The proceeds will be used to strengthen capital, he said, adding that a Malaysian conglomerate involved in agribusiness and pharmaceutical distribution has expressed an interest in buying the shares. The deal is expected to be finalized before the end of this year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INAF:IJ 291.00 +17.00

INAF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for INAF.
View Industry Companies
 

Industry Analysis

INAF

Industry Average

Valuation INAF Industry Range
Price/Earnings 100.0x
Price/Sales 0.6x
Price/Book 1.5x
Price/Cash Flow 745.5x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INDOFARMA TBK PT, please visit www.indofarma.co.id. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.